This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.
In this paper, an overview is provided of the present Italian generic medicines system. Data on generic medicines market share and enterprise performance were reviewed and discussed, and the results of a survey completed by general practitioners (Computer Assisted Web Interview), pharmacists (Computer Assisted Web Interview) and patients (Computer Assisted Personal Interview) are presented. How potential policies on manufacturing and exports affect the industry in Italy are also explored. The results show that generic medicines in Italy have a lower market share than in other major European countries. This is mainly because general practitioners are uncomfortable with generic medicines companies, in particular those whose chain of production is unclear to them. A series of obstacles to diffusion of generic medicines also persists at a legislative level, such as payback and patent linkage. Manufacturing and exports in Italy could benefit from the manufacture of generic medicines before patent expiry, which would enable exports to countries with different expiry dates.
At the end of 2011, a study was commissioned by EFSA to the Consortium Nomisma-Areté, with the objective of gathering consumption data for “energy” drinks (ED) in specific consumer groups (adults, adolescents and children) in EU). The study also aims at estimating, for the different consumer groups, the exposure to specific active ingredients (caffeine, taurine, and D-glucurono-y-lactone) from ED consumption, and the relative contribution of ED to the total caffeine exposure. Moreover, specific consumption habits (co-consumption with alcohol and consumption associated to intense physical exercise) should be analysed for adolescents and adults.
Between February and November 2012, the study team conducted an EU-wide questionnaire-based survey - involving more than 52.000 participants from 16 different EU Member States7(MS) - among adults (14.500 participants), adolescents (32.000), and children (5.500).
The objective of this study is to make an assessment of the socio-economic importance in European agriculture of azoles active substances. In order to evaluate the actual relevance of this class of compounds, the economic impact of a withdrawal from use of azoles has been estimated, considering the specific case study of wheat.
The evaluation of the impact has been carried out by taking into account the future trends of the main variables,
which are yield, area, production, trade balance, consumption and self-sufficiency. The time frames of the analysis consider a short term impact analysis (2013) and a long term one (2020).
In the short term evaluation, rates of yield reduction have been used to estimate the drop in production linked to the increased diseases occurrence and to related effects that could arise from the withdrawal from use of azole fungicides. In the long term analysis, the development of resistance for the remaining fungicides has been considered along with the yield reduction effect: specifically, in a long term horizon the increasing selection pressure for the remaining fungicides would result in a lack of protection regarding diseases and would cause difficulties in managing them.
The impact analysis carried out by Nomisma has outlined some very clear results.
· The projections have shown that, with azoles still in use, wheat yield and cultivated areas would continue to increase in the next few years, resulting in an overall growth of wheat production that has been estimated at
+5.0% in 2013 and +13.4% in 2020. According to these trends, the European Union would remain a net exporter
of wheat and would continue to produce more wheat than what is being consumed.
· The yield of wheat would decrease in the hypothesis that the use of azoles ceased resulting in a loss of production (leaving all other variables constant) of 9.9 millions of tons in 2013 (from 141.1 to 131.3) and 18,6 millions of tons in 2020 (from 152.4 to 133.8). This decreasing production would not only mean a loss of value of 2.4 billion euros in 2013 and 4.6 billion euros in 2020. It would also mean that the European Union would be unable to satisfy its internal demand and maintain a 100% self-sufficiency rate.
· An analysis has also been made of key variables (namely imports, exports, stocks and cultivated area) that would need to adjust to compensate for the reduction of the yield and to guarantee a 100% demand satisfaction rate and a 100% self-sufficiency rate. While there would be substantial changes in all variables, it is particularly significant (and unrealistic) that the cultivated area would need to increase by 7.5% in the short term scenario and by 13.9% in the long term scenario.
· The role of azoles is highlighted in maintaining the European Union’s position as a net exporter. The sensitivity of the world price to changes in the EU are also highlighted given that it is a primary player in term of production (it accounts for 21% of total wheat production), productivity (European yield is 5.3 t/ha while the global average is 2.9 t/ha) and trade (it contributes to 16.8% of world wheat trade flows).
· In conclusion, the study shows that the economic relevance of azoles in the European Union is considerable, as their hypothetical loss would have significant relapses on both the domestic market and international markets.
On the internal market, we estimate that without azoles there would be a drop in domestic production, leading to a deterioration of the demand satisfaction rate and to higher prices. This could in turn imply that the European Union could cease to be a net exporter at world level, bringing into question the possibility of the other big wheat supplier (North and South America, Australia, Russia, etc.) to be able to satisfy the global demand. This would increase the current uncertainty concerning global food security, bringing further consequences – which have been prominently emerging over the last years - such as drop in stocks, increase of prices and price volatility upsurge.
... Observational studies conducted among children and adolescents have limitations that prevent the confirmation of definite cause-and-effect relationships. Therefore, due to the lack of sufficient data on the relationship between caffeine intake and health outcomes in the paediatric population, experts from the European Food Safety Authority (EFSA) have yet to determine a safe daily dose of caffeine for children [10]. ...
... It is an integrated approach that utilizes appropriate physical, chemical, and biological methods of control. Empirical evidence suggests that careful application of IPM practices can be a viable way to prevent the overuse and unnecessary application of pesticides without incurring significant yield losses (Jacquet et al. 2011, Lechenet et al. 2014, 2017 though this is debated (Di Tullio et al. 2012, Hossard et al. 2014. ...
... The SSN currently only reimburses Class A medicines at the lowest price available: if patients opt to purchase a branded, more expensive version of the drug, the cost difference is paid by the user. Despite such efforts, in 2014 generic medicines accounted for barely 13 percent of spending on Class A medicines, and constituted only 7.7 percent of the total pharmaceutical market in terms of value and 22.1 percent in terms of volume (Piccinni et al. 2016;OECD 2019a). ...
... Energy Drinks (EDs) has become one of the most popular beverages worldwide. They are defined as any type of non-alcoholic beverages that contains caffeine as a main ingredient, taurine, vitamins, and other ingredients combination (such as guarana and ginseng, etc.) (Metrology, 2015;Zucconi, 2013). They are marketed as to relieve fatigue and improve mental alertness, in contrast with sports or isotonic drinks which are intended to help athletes rehydrate after exercise (Campbell et al., 2013;Schneider & Benjamin, 2011). ...